The stock tumbled 19% at the opening bell in Copenhagen after its outlook for the year ahead disappointed investors.
Lawsuit claims Novo Nordisk delayed generic Victoza using patent tactics and settlements, preserving monopoly pricing and ...
Amid a viral social media trend glorifying the halcyon days of 2016, Novo Nordisk has gone back an extra decade to find ...
Novo Nordisk is worried about competition and wants to be seen as the cool kid... by using a 20-year-old ad format.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results